Evidence map›Paper›PMID 33230925›Full record

ReviewPhysiological reports2020

Emerging roles of Sox6 in the renal and cardiovascular system.

Mohammad Saleem, Pierina Barturen-Larrea, Jose A Gomez

Open access · goldAbstract readReview
In one paragraph

Review in Physiological reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammad SaleemDepartment of Medicine / Clinical Pharmacology Division, Vanderbilt University Medical Center, Nashville, TN, USA.
Pierina Barturen-LarreaDepartment of Medicine / Clinical Pharmacology Division, Vanderbilt University Medical Center, Nashville, TN, USA.
Jose A GomezDepartment of Medicine / Clinical Pharmacology Division, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-8148-8308
Vanderbilt University Medical Center · US

Funding

Sox6 Role in Renin Expression During Juxtaglomerular Cells ExpansionK01HL135461 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOMEZ, JOSE A. · 2017 to 2021
$850k
NHLBI NIH HHS 1K01HL135461NHLBI NIH HHS K01 HL135461
6 · The paper itself

Abstract

The function of Sex-determining Region Y (SRY)-related high-mobility-group box (Sox) family of transcription factors in cell fate decisions during embryonic development are well-established. Accumulating evidence indicates that the Sox family of transcription factors are fundamental in adult tissue homeostasis, regeneration, and physiology. The SoxD subfamily of genes are expressed in various cell types of different organs during embryogenesis and adulthood and have been involved in cell-fate determination, cellular proliferation and survival, differentiation, and terminal maturation in a number of cell lineages. The dysregulation in the function of SoxD proteins (i.e. Sox5, Sox6, Sox13, and Sox23) have been implicated in different disease conditions such as chondrodysplasia, cancer, diabetes, hypertension, autoimmune diseases, osteoarthritis among others. In this minireview, we present recent developments related to the transcription factor Sox6, which is involved in a number of diseases such as diabetic nephropathy, adipogenesis, cardiomyopathy, inflammatory bowel disease, and cancer. Sox6 has been implicated in the regulation of renin expression and JG cell recruitment in mice during sodium depletion and dehydration. We provide a current perspective of Sox6 research developments in last five years, and the implications of Sox6 functions in cardiovascular physiology and disease conditions.

Indexed as

AnimalsCardiovascular DiseasesCardiovascular SystemDiabetes MellitusHumansKidneyReninSOXD Transcription FactorsReninSOXD Transcription Factors

Identifiers

PMID33230925
PMCPMC7683808
OpenAlexW3109611291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.